🔎 Trials Near Me

Beranda › Depresi › Arkansas

Uji klinis Depresi di Arkansas

10 studi untuk Depresi mencari peserta di lokasi di Arkansas.

Kota di Arkansas

Teks studi resmi (Bahasa Inggris)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Pillar Clinical Research, Bentonville
  • SanRo Clinical Research Group, Bryant
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Little Rock
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bentonville
  • Draig Clinical Site, Little Rock
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06911112

E-Mindfulness Approaches for Living After Breast Cancer

  • Mercy Hospital Fort Smith, Fort Smith
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
Menerima pesertaFase 3
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Woodland International Research Group, Little Rock
  • Woodland Research Northwest, Rogers
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
  • Neurocrine Clinical Site, Little Rock
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Pillar Clinical Research, LLC, Little Rock
  • Preferred Research Partners, Inc., Little Rock
  • Woodland Research Northwest, Rogers
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

  • University of Arkansas for Medical Sciences, Little Rock
  • Northeast Arkansas Community Corrections Center (NEACC), Osceola
  • Southwest Arkansas Community Correction Center, Texarkana
  • dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT06923423

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Little Rock
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06786624

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.